Huron Consulting Group Inc. annual report, FY2023

Huron Consulting Group Inc. — FY2023 Form 10-K Summary

Reporting period: Fiscal year ended December 31, 2023. Although the request references 2023 Q4, this filing is an annual Form 10-K and reports full-year results; fourth-quarter results are not separately presented in the supplied filing text.

Business Context

Huron is a global professional services firm focused on consulting, managed services, digital transformation, technology, data and analytics. Its reportable segments are Healthcare, Education and Commercial, which represented approximately 49%, 32% and 19% of 2023 revenue, respectively. Huron served nearly 2,000 clients and had approximately 6,480 full-time professionals at year-end, including 5,519 revenue-generating professionals.

Key Financial Metrics

Metric20232022Change
Revenue$1.362 billion$1.132 billion+20.3%
Operating income$125.3 million$99.8 million+25.7%
Operating margin9.2%8.8%+40 basis points
Net income$62.5 million$75.6 million-17.3%
Diluted EPS$3.19$3.64-12.4%
Adjusted EBITDA$167.3 million$130.8 million+27.9%
Adjusted EBITDA margin12.3%11.6%+70 basis points
Adjusted diluted EPS$4.91$3.43+43.1%
Cash flow from operations$135.3 million$85.4 million+58.4%

Consulting and Managed Services revenue increased 22.6% to $782.0 million, while Digital revenue increased 17.3% to $580.0 million. Consulting utilization rose to 76.6% from 75.2%, and Digital utilization rose to 75.3% from 71.0%.

Segment revenue and operating income were: Healthcare revenue of $674.0 million and operating income of $172.9 million; Education revenue of $429.7 million and operating income of $99.1 million; and Commercial revenue of $258.4 million and operating income of $54.2 million.

Liquidity, Cash Flow and Debt

  • Cash and cash equivalents were $12.1 million at December 31, 2023.
  • Net cash provided by operating activities was $135.3 million. Investing cash use was $36.7 million, including $25.7 million for internally developed software and $9.4 million for property and equipment. Financing cash use was $98.3 million.
  • Debt outstanding under the senior secured revolving credit facility was $324.0 million, compared with $290.0 million at year-end 2022. Unused borrowing capacity was $275.5 million, subject to outstanding letters of credit and credit agreement terms.
  • The revolving facility matures November 15, 2027, bears variable-rate interest tied to Term SOFR or an alternate base rate, and is secured by substantially all relevant assets and certain subsidiary equity interests.
  • The December 31, 2023 consolidated leverage ratio was 1.59x and interest coverage ratio was 10.85x; Huron was in compliance with its financial covenants.
  • In February 2024, Huron established a $275 million term loan facility, with proceeds intended to reduce revolving borrowings. Quarterly amortization of $3.4 million begins June 30, 2024.
  • Huron repurchased 1,461,815 shares for $123.6 million during 2023. The remaining share repurchase authorization was $86.2 million as of December 31, 2023 and expires December 31, 2024. Huron has not paid common stock dividends since becoming public.

Material Changes Versus 2022

  • Revenue growth was broad-based, led by Healthcare, up 26.0%, and Education, up 19.4%; Commercial increased 8.7%.
  • Operating margin expanded as revenue growth exceeded increases in operating expenses, despite higher compensation, performance bonus and support costs.
  • Net income and GAAP EPS declined primarily because 2023 included a $26.3 million non-cash impairment loss on a hospital-at-home preferred stock investment, while 2022 included a $27.0 million non-cash unrealized gain on the same investment.
  • Adjusted EBITDA and adjusted EPS increased substantially after excluding the preferred stock investment loss and other specified items.
  • Restructuring charges increased to $11.6 million from $9.9 million, including office exits, lease and fixed-asset impairments, severance and abandonment of a capitalized software project.
  • Unbilled services increased to $190.9 million from $141.8 million, and contract assets increased to $70.1 million from $50.2 million, reflecting timing differences between revenue recognition and contractual billing.
  • Goodwill and other intangible assets totaled $643.8 million, or approximately 51% of total assets. No goodwill or intangible asset impairment was recorded in 2023.

Outlook, Commentary and Risks

Management emphasizes continued growth in Healthcare and Education, expansion in Commercial industries, development of digital capabilities and margin expansion through operating efficiency and scale. The filing does not provide a clear numerical 2024 revenue, earnings or margin guidance value in the supplied text. Huron estimates 2024 purchases of property and equipment and software development will total approximately $35 million to $40 million.

  • Remaining performance obligations under engagements with original expected durations longer than one year were $227.8 million at year-end; approximately $82.7 million was expected to be recognized in 2024, $54.3 million in 2025 and $90.8 million thereafter. These amounts exclude constrained variable consideration and time-and-expense engagements.
  • Huron agreed in February 2024 to acquire Grenzebach Glier and Associates, with expected closing in March 2024. Management does not expect the transaction to be significant to consolidated financial statements.
  • Key operating risks include dependence on retaining senior leaders and skilled professionals, utilization and billing rates, short-term and terminable client contracts, competition, client concentration in Healthcare and Education, regulatory changes, technology and third-party provider dependence, cybersecurity and data privacy, AI-related risks, foreign operations, interest rates, client collections and goodwill impairment.
  • Huron reported no cybersecurity incident that had a material adverse impact on the business or operations as of the filing date. Management and the independent auditor concluded that internal control over financial reporting was effective as of December 31, 2023.
  • The independent auditor identified revenue recognition for fixed-fee and Healthcare performance-based arrangements as a critical audit matter because of management’s estimates regarding progress, total engagement costs and variable consideration.

Most Important Facts to Verify

  • Whether Healthcare and Education demand, utilization and hiring trends remain strong enough to support continued revenue and margin expansion.
  • The composition and collectability of the elevated $190.9 million unbilled services balance and $70.1 million of contract assets.
  • The impact of the February 2024 $275 million term loan on interest expense, leverage, liquidity and share repurchase capacity.
  • Whether the hospital-at-home investment requires further impairment beyond the $26.3 million 2023 non-cash loss.
  • The sustainability of adjusted EBITDA and adjusted EPS after excluding investment gains or losses, restructuring charges and other non-GAAP adjustments.
  • Progress and purchase price terms for the proposed GG+A acquisition and any additional acquisition activity.
  • Potential effects of professional-services talent costs, client cancellations, healthcare and education regulation, cybersecurity incidents and changes in interest rates.